IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v60y2005i6p1197-1208.html
   My bibliography  Save this article

Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective

Author

Listed:
  • Slack, C.
  • Stobie, M.
  • Milford, C.
  • Lindegger, G.
  • Wassenaar, D.
  • Strode, A.
  • IJsselmuiden, C.

Abstract

HIV treatment for participants who become infected during HIV vaccine trials has been the focus of ethical controversy. The obligations of sponsors to ensure that participants have access to antiretrovirals have been a particular focus of this debate. This paper presents three arguments that have been made in this regard, and some of their limitations, in anticipation of HIV vaccine trials in South Africa. The first argument is that HIV risk behaviour increases in such trials, and HIV infection can be viewed as a research-related injury, justifying sponsor provision of treatment on grounds of compensation for harm. We conclude that risk-behaviour studies to date do not show general increases in risk behaviour that could constitute the basis for a general obligation. Participation may well adversely impact on risk behaviour for some individuals, and conceivably this could be demonstrated. This argument may, therefore, have merit at the individual level; however, it seems a weak platform from which to argue that sponsors should treat all HIV infections acquired during trials. The second argument is that treatment should be provided based on distributive justice. We conclude that traditional concepts of "distributive justice" in research appear limited in justifying obligations of sponsors to ensure access to antiretrovirals. Further, using research initiatives to reduce global health care inequities is controversial, and even proponents may disagree about the fairest use of finite resources. The third argument is that sponsors should ensure antiretroviral access on grounds of beneficence; namely, the maxim that if one can do something beneficial without sacrificing anything of comparable significance, it ought to be done. Thus, sponsors should provide more interventions than those minimally required to conduct the research. However, beneficence may demand levels of altruism that exceeds what is reasonable. While the latter arguments may provide stronger justifications than the first, it is difficult to use these arguments to establish that sponsor provision of antiretrovirals to infected individuals is obligatory.

Suggested Citation

  • Slack, C. & Stobie, M. & Milford, C. & Lindegger, G. & Wassenaar, D. & Strode, A. & IJsselmuiden, C., 2005. "Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective," Social Science & Medicine, Elsevier, vol. 60(6), pages 1197-1208, March.
    • Handle: RePEc:eee:socmed:v:60:y:2005:i:6:p:1197-1208
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277-9536(04)00335-1
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Benatar, S. R., 2002. "Reflections and recommendations on research ethics in developing countries," Social Science & Medicine, Elsevier, vol. 54(7), pages 1131-1141, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Simon, Christian & Mosavel, Maghboeba & van Stade, Debbie, 2007. "Ethical challenges in the design and conduct of locally relevant international health research," Social Science & Medicine, Elsevier, vol. 64(9), pages 1960-1969, May.
    2. Heimer, Carol A., 2013. "‘Wicked’ ethics: Compliance work and the practice of ethics in HIV research," Social Science & Medicine, Elsevier, vol. 98(C), pages 371-378.
    3. Burgess, Michael M., 2007. "Proposing modesty for informed consent," Social Science & Medicine, Elsevier, vol. 65(11), pages 2284-2295, December.
    4. Mwiti, Fredah & Goulding, Christina, 2018. "Strategies for community improvement to tackle poverty and gender issues: An ethnography of community based organizations (‘Chamas’) and women's interventions in the Nairobi slums," European Journal of Operational Research, Elsevier, vol. 268(3), pages 875-886.
    5. Barsdorf, Nicola Wendy & Wassenaar, Douglas Richard, 2005. "Racial differences in public perceptions of voluntariness of medical research participants in South Africa," Social Science & Medicine, Elsevier, vol. 60(5), pages 1087-1098, March.
    6. Catherine Molyneux & Jane Goudge & Steve Russell & Jane Chuma & Tebogo Gumede & Lucy Gilson, 2009. "Conducting health-related social science research in low income settings: ethical dilemmas faced in Kenya and South Africa," Journal of International Development, John Wiley & Sons, Ltd., vol. 21(2), pages 309-326.
    7. Kamat, Vinay R., 2014. "Fast, cheap, and out of control? Speculations and ethical concerns in the conduct of outsourced clinical trials in India," Social Science & Medicine, Elsevier, vol. 104(C), pages 48-55.
    8. Molyneux, Sassy & Geissler, P. Wenzel, 2008. "Ethics and the ethnography of medical research in Africa," Social Science & Medicine, Elsevier, vol. 67(5), pages 685-695, September.
    9. Valdez-Martinez, Edith & Trumbull, Bernardo & Garduno-Espinosa, Juan & Porter, John David Henley, 2005. "Understanding the structure and practices of research ethics committees through research and audit: a study from Mexico," Health Policy, Elsevier, vol. 74(1), pages 56-68, September.
    10. Dawson, Liza & Kass, Nancy E., 2005. "Views of US researchers about informed consent in international collaborative research," Social Science & Medicine, Elsevier, vol. 61(6), pages 1211-1222, September.
    11. Gikonyo, Caroline & Bejon, Philip & Marsh, Vicki & Molyneux, Sassy, 2008. "Taking social relationships seriously: Lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast," Social Science & Medicine, Elsevier, vol. 67(5), pages 708-720, September.
    12. Grol-Prokopczyk, Hanna, 2013. "Thai and American doctors on medical ethics: Religion, regulation, and moral reasoning across borders," Social Science & Medicine, Elsevier, vol. 76(C), pages 92-100.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:60:y:2005:i:6:p:1197-1208. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.